Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Nature Medicine

Volumn 10, Issue 2, 2004, Pages 145-147

  Willett, Christopher G ^a   Boucher, Yves ^a   Di Tomaso, Emmanuelle ^a   Duda, Dan G ^a   Munn, Lance L ^a   Tong, Ricky T ^a   Chung, Daniel C ^a   Sahani, Dushyant V ^a   Kalva, Sanjeeva P ^a   Kozin, Sergey V ^a   Mino, Mari ^a   Cohen, Kenneth S ^a   Scadden, David T ^a   Hartford, Alan C ^a   Fischman, Alan J ^a   Clark, Jeffrey W ^a   Ryan, David P ^a   Zhu, Andrew X ^a   Blaszkowsky, Lawrence S ^a   Chen, Helen X ^b   Shellito, Paul C ^a   Lauwers, Gregory Y ^a   Jain, Rakesh K ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL; BLOOD VOLUME; CANCER PATIENT; CELL COUNT; CELL VIABILITY; CIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DRUG ACTIVITY; DRUG EFFECT; DRUG INFUSION; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; MICROVASCULATURE; PERFUSION; PERICYTE; PRIORITY JOURNAL; RECTUM CANCER; STEM CELL; TISSUE PRESSURE; TUMOR VASCULARIZATION; ADENOCARCINOMA; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHASE 1 CLINICAL TRIAL; RECTUM TUMOR;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; HUMANS; RECTAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 11144354392     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm988     Document Type: Article

References (15)

1. Carmeliet, P. & Jain, R.K. Nature 407, 249-257 (2000).
2. Dvorak, H.F. J. Clin. Oncol. 20, 4368-4380 (2002).
3. Ferrara, N., Gerber, H.P. & LeCouter, J. Nat. Med. 9, 669-676 (2003).
4. Kerbel, R. & Folkman, J. Nat. Rev. Cancer 2, 727-739 (2002).
5. McCarthy, M. Lancet 361, 1959 (2003).
6. Lee, C. et al. Cancer Res. 60, 5565-5570 (2000).
7. Yuan, F. et al. Proc. Natl. Acad. Sci. USA 93, 14765-14770 (1996).
8. Jain, R.K. Nat. Med. 7, 987-989 (2001).
9. Jain, R.K. Nat. Med. 9, 685-693 (2003).
10. Wildiers, H. et al. Br. J. Cancer 88, 1979-1986 (2003).
11. Rafii, S. et al. Nat. Rev. Cancer 2, 826-835 (2002).
12. Mancuso, P. et al. Blood 97, 3658-3661 (2001).
13. Monestiroli, S. et al. Cancer Res. 61, 4341-4344 (2001).
14. Yang, J.C. et al. N. Engl. J. Med. 349, 427-434 (2003).
15. Teicher, B.A. Cancer Metastasis Rev. 15, 247-272 (1996).